These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7942619)

  • 1. Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists.
    True LD
    Am J Clin Pathol; 1994 Nov; 102(5):572-9. PubMed ID: 7942619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of the 2005 International Society of Urological Pathology Gleason Grading System in prostate biopsy and radical prostatectomy specimens.
    Trpkov K; Zhang J
    BJU Int; 2009 Sep; 104(5):722-3. PubMed ID: 19689580
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.
    Bostwick DG; Montironi R
    Virchows Arch; 1997 Jan; 430(1):1-16. PubMed ID: 9037309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on prostate pathology.
    Osunkoya AO
    Pathology; 2012 Aug; 44(5):391-406. PubMed ID: 22772344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies.
    Montironi R; Mazzuccheli R; Scarpelli M; Lopez-Beltran A; Fellegara G; Algaba F
    BJU Int; 2005 Jun; 95(8):1146-52. PubMed ID: 15877724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [COMPARISON LOCALIZATION RESULTS BASED ON PROSTATE BIOPSY SPECIMENS WITH RESULTS BASED ON RADICAL PROSTATECTOMY SPECIMENS IN PROSTATE CANCER].
    Nishikimi T; Tsuzuki T; Oohashi T; Yamauchi Y; Ishida R; Yamada H; Yokoi K; Kobayashi H
    Nihon Hinyokika Gakkai Zasshi; 2016; 107(2):87-92. PubMed ID: 28442675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.
    Evans AJ; Henry PC; Van der Kwast TH; Tkachuk DC; Watson K; Lockwood GA; Fleshner NE; Cheung C; Belanger EC; Amin MB; Boccon-Gibod L; Bostwick DG; Egevad L; Epstein JI; Grignon DJ; Jones EC; Montironi R; Moussa M; Sweet JM; Trpkov K; Wheeler TM; Srigley JR
    Am J Surg Pathol; 2008 Oct; 32(10):1503-12. PubMed ID: 18708939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of digital maps and sampling of radical prostatectomy specimens.
    Trpkov K; Warman L
    Arch Pathol Lab Med; 2006 Dec; 130(12):1751-2; author reply 1752. PubMed ID: 17149939
    [No Abstract]   [Full Text] [Related]  

  • 10. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
    Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond ME
    Arch Pathol Lab Med; 2014 Oct; 138(10):1387-405. PubMed ID: 25092589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interobserver variability in the pathological assessment of radical prostatectomy specimens: findings of the Laparoscopic Prostatectomy Robot Open (LAPPRO) study.
    Persson J; Wilderäng U; Jiborn T; Wiklund PN; Damber JE; Hugosson J; Steineck G; Haglind E; Bjartell A
    Scand J Urol; 2014 Apr; 48(2):160-7. PubMed ID: 23906418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gleason score concordance on biopsy-confirmed prostate cancer: is pathological re-evaluation necessary prior to radical prostatectomy?
    Truesdale MD; Cheetham PJ; Turk AT; Sartori S; Hruby GW; Dinneen EP; Benson MC; Badani KK
    BJU Int; 2011 Mar; 107(5):749-754. PubMed ID: 20840549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Discrepancy between Gleason score of needle biopsies and radical prostatectomy specimens--current situation of general pathologists].
    Kato T; Nakano M; Uno H; Seike K; Kojima K; Kubota Y; Goto T; Yamamoto N; Ehara H; Kanimoto Y; Takahashi Y; Deguchi T
    Hinyokika Kiyo; 2008 Oct; 54(10):641-5. PubMed ID: 19048927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens.
    Amin M; Boccon-Gibod L; Egevad L; Epstein JI; Humphrey PA; Mikuz G; Newling D; Nilsson S; Sakr W; Srigley JR; Wheeler TM; Montironi R
    Scand J Urol Nephrol Suppl; 2005 May; (216):20-33. PubMed ID: 16019757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy specimens among Medicare patients in New York State: a review of pathologists' reports.
    Imperato PJ; Waisman J; Nenner RP
    Arch Pathol Lab Med; 1998 Nov; 122(11):966-71. PubMed ID: 9822124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Gleason scores between needle-core biopsy and radical prostatectomy specimens in patients with prostate cancer.
    Hsieh TF; Chang CH; Chen WC; Chou CL; Chen CC; Wu HC
    J Chin Med Assoc; 2005 Apr; 68(4):167-71. PubMed ID: 15850066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dataset for the reporting of prostate carcinoma in core needle biopsy and transurethral resection and enucleation specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Egevad L; Judge M; Delahunt B; Humphrey PA; Kristiansen G; Oxley J; Rasiah K; Takahashi H; Trpkov K; Varma M; Wheeler TM; Zhou M; Srigley JR; Kench JG
    Pathology; 2019 Jan; 51(1):11-20. PubMed ID: 30477882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of outcomes after radical prostatectomy in patients diagnosed with prostate cancer of biopsy Gleason score ≥ 8 via contemporary multi (≥ 12)-core prostate biopsy.
    Hong SK; Oh JJ; Jeong SJ; Jeong CW; Kim IS; Park JM; Byun SS; Choe G; Lee HJ; Lee SE
    BJU Int; 2011 Jul; 108(2):217-22. PubMed ID: 21083642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International society of urological pathology consensus conference on handling and staging of radical prostatectomy specimens.
    Egevad L; Srigley JR; Delahunt B
    Adv Anat Pathol; 2011 Jul; 18(4):301-5. PubMed ID: 21654361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A contemporary study correlating prostate needle biopsy and radical prostatectomy Gleason score.
    Fine SW; Epstein JI
    J Urol; 2008 Apr; 179(4):1335-8; discussion 1338-9. PubMed ID: 18289601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.